Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review

  • ID: 4225268
  • SWOT Analysis
  • 54 pages
  • GlobalData
  • Celsion Corporation
1 of 5

FEATURED COMPANIES

  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Clovis Oncology Inc
  • Genentech Inc
  • Merck & Co Inc
  • Tesaro Inc
  • MORE
Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence provide the foundation for a wide range of treatments for common and difficult-to-treat forms of cancers. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma (HCC) and a Phase II clinical trial for recurrent chest wall (RCW) breast cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents. Celsion is headquartered in Lawrenceville, New Jersey, the US.

Celsion Corp Key Recent Developments

May 11, 2018: Celsion Reports First Quarter 2018 Financial Results and Provides Business Update
Mar 27, 2018: Celsion Announces Fourth Quarter And Full-Year 2017 Financial Results
Jan 18, 2018: Celsion Provides Corporate Update and 2018 Outlook
Nov 14, 2017: Celsion Reports Third Quarter 2017 Financial Results and Provides Business Update
Oct 18, 2017: Celsion Provides Summary of Research and Development Day Held on October 12, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Clovis Oncology Inc
  • Genentech Inc
  • Merck & Co Inc
  • Tesaro Inc
  • MORE
Section 1 - About the Company
  • Celsion Corp - Key Facts
  • Celsion Corp - Key Employees
  • Celsion Corp - Key Employee Biographies
  • Celsion Corp - Major Products and Services
  • Celsion Corp - History
  • Celsion Corp - Company Statement
  • Celsion Corp - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Celsion Corp - Business Description
  • Celsion Corp - Corporate Strategy
  • Celsion Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Celsion Corp - Strengths
  • Celsion Corp - Weaknesses
  • Celsion Corp - Opportunities
  • Celsion Corp - Threats
  • Celsion Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Celsion Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 11, 2018: Celsion Reports First Quarter 2018 Financial Results and Provides Business Update
  • Jan 18, 2018: Celsion Provides Corporate Update and 2018 Outlook
  • Nov 14, 2017: Celsion Reports Third Quarter 2017 Financial Results and Provides Business Update
  • Oct 18, 2017: Celsion Provides Summary of Research and Development Day Held on October 12, 2017
  • Aug 15, 2017: Celsion Reports Second Quarter 2017 Financial Results and Provides Business Update
  • Aug 04, 2017: Celsion to Delist from the Tel Aviv Stock Exchange
  • May 12, 2017: Celsion Reports First Quarter 2017 Financial Results and Provides Business Update
  • Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Celsion Corp, Key Facts
  • Celsion Corp, Key Employees
  • Celsion Corp, Key Employee Biographies
  • Celsion Corp, Major Products and Services
  • Celsion Corp, History
  • Celsion Corp, Key Competitors
  • Celsion Corp, Ratios based on current share price
  • Celsion Corp, Annual Ratios
  • Celsion Corp, Annual Ratios (Cont...1)
  • Celsion Corp, Interim Ratios
  • Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Celsion Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Celsion Corp, Performance Chart (2013 - 2017)
  • Celsion Corp, Ratio Charts
  • Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Tesaro Inc
  • Merck & Co Inc
  • Genentech Inc
  • Clovis Oncology Inc
  • Bristol-Myers Squibb Co
  • Amgen Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll